Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing Gan Jie Yu Herbal Formula Granule (also known as Qinggan Jieyu decoction or QGJY) is a traditional Chinese medicine (TCM) herbal formula developed by the Department of Neurology at Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine [ChiCTR-TRC-14004469]. It is formulated to treat liver meridian stagnant heat syndrome (liver depression of heat syndrome) presenting as migraine, non-organic insomnia, or anxiety [ChiCTR-TRC-14004469]. The formula consists of several Chinese herbal medicines, including Chaihu (*Radix Bupleuri Chinensis*), Huangqin (*Radix Scutellariae Baicalensis*), Yujin (*Radix Curcumae Wenyujin*), Zhuru (*Caulis Bambusae in Taeniam*), Jili (*Fructus Tribuli*), and Mohanlian (*Herba Ecliptae prostratae*). In clinical trials, it has demonstrated efficacy in improving sleep quality, sleep duration, and psychological health, as well as reducing migraine frequency and severity, potentially by downregulating purinergic receptor P2X7R expression and suppressing microglial activation and autophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qing gan jie yu herbal formula granule.